View Cart  

Consent Decree Remains Likely for Hospira as Negative Inspections Continue: Analyst

A A
Hospira continues to remain at risk for a consent decree as negative manufacturing updates, additional form 483 observations and product recalls pile up, one analyst says.

To View This Article:

Login

Subscribe To Drug Industry Daily